source
- Hemab Therapeutics IPO raises $301.5M, stock triples and funds runway to 2029Hemab Therapeutics completed an upsized $301.5 million IPO in May, boosting total proceeds to $346.7 million. The offering helped the company’s share price climb from $18 at debut to $53.48 by mid‑…
- Experts warn splitting MMR vaccine into separate shots could increase missed doses and illnessThe article notes that a recent executive order proposes separating the combined measles, mumps and rubella vaccine into three individual injections. The author argues that this change could lead t…